| Product Code: ETC9212686 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Serbia Malaria Vaccine Market Overview |
3.1 Serbia Country Macro Economic Indicators |
3.2 Serbia Malaria Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Serbia Malaria Vaccine Market - Industry Life Cycle |
3.4 Serbia Malaria Vaccine Market - Porter's Five Forces |
3.5 Serbia Malaria Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Serbia Malaria Vaccine Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.7 Serbia Malaria Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Serbia Malaria Vaccine Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Serbia Malaria Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing government initiatives and funding for malaria prevention and control programs in Serbia |
4.2.2 Growing awareness among the population about the importance of vaccination in preventing malaria |
4.2.3 Rising incidences of malaria cases in Serbia leading to a higher demand for vaccines |
4.3 Market Restraints |
4.3.1 Limited availability and accessibility of malaria vaccines in Serbia |
4.3.2 High costs associated with the development and distribution of malaria vaccines in the market |
5 Serbia Malaria Vaccine Market Trends |
6 Serbia Malaria Vaccine Market, By Types |
6.1 Serbia Malaria Vaccine Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Serbia Malaria Vaccine Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Serbia Malaria Vaccine Market Revenues & Volume, By Pre-Erythrocytic Vaccine, 2021- 2031F |
6.1.4 Serbia Malaria Vaccine Market Revenues & Volume, By Erythrocytic Vaccine, 2021- 2031F |
6.1.5 Serbia Malaria Vaccine Market Revenues & Volume, By Multi-Antigen Vaccine, 2021- 2031F |
6.2 Serbia Malaria Vaccine Market, By Agent |
6.2.1 Overview and Analysis |
6.2.2 Serbia Malaria Vaccine Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.2.3 Serbia Malaria Vaccine Market Revenues & Volume, By Plasmodium Vivax, 2021- 2031F |
6.2.4 Serbia Malaria Vaccine Market Revenues & Volume, By Anopheles Species, 2021- 2031F |
6.3 Serbia Malaria Vaccine Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 Serbia Malaria Vaccine Market Revenues & Volume, By Intramuscular, 2021- 2031F |
6.3.3 Serbia Malaria Vaccine Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.3.4 Serbia Malaria Vaccine Market Revenues & Volume, By Intradermal, 2021- 2031F |
6.4 Serbia Malaria Vaccine Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 Serbia Malaria Vaccine Market Revenues & Volume, By NGO/Non-Profit Organization, 2021- 2031F |
6.4.3 Serbia Malaria Vaccine Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.4 Serbia Malaria Vaccine Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.5 Serbia Malaria Vaccine Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 Serbia Malaria Vaccine Market Import-Export Trade Statistics |
7.1 Serbia Malaria Vaccine Market Export to Major Countries |
7.2 Serbia Malaria Vaccine Market Imports from Major Countries |
8 Serbia Malaria Vaccine Market Key Performance Indicators |
8.1 Number of government-supported malaria vaccination campaigns conducted annually in Serbia |
8.2 Percentage increase in the vaccination coverage rate for malaria in Serbia |
8.3 Number of new partnerships formed between vaccine manufacturers and healthcare providers in Serbia to improve vaccine distribution and accessibility |
9 Serbia Malaria Vaccine Market - Opportunity Assessment |
9.1 Serbia Malaria Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Serbia Malaria Vaccine Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.3 Serbia Malaria Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 Serbia Malaria Vaccine Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 Serbia Malaria Vaccine Market - Competitive Landscape |
10.1 Serbia Malaria Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Serbia Malaria Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here